Postgraduate Studentships - Search for funding opportunities.
Postgraduate Studentships - Search for funding opportunities.
Study Details: MSc 1 year full-time, 2 years part-time or 5 years flexible
Embrace one of the fastest paced sectors in health through this cutting-edge Master’s degree that focuses on the business and management of biotechnology and pharmaceutical ventures.
This cutting-edge programme integrates business with biotechnology and pharmaceuticals. It has been meticulously crafted by academics and industry experts at the world’s first business school dedicated to health.
Offered by a global top 10 university, the Biotech and Pharmaceutical Management MSc provides a unique opportunity to learn from the best in the sector and enhance your future employability.
With the growing need for new drug development in response to emerging global medical challenges, applying a business mindset to this area of health is becoming increasingly vital. The Biotech and Pharmaceutical Management MSc equips students with the managerial tools necessary to bring biotechnology and pharmaceutical innovations to highly regulated markets.
An upper second-class UK Bachelor’s degree in a health, science, business or economics related subject or an overseas qualification of an equivalent standard. Graduates without the relevant degree classification but with extensive relevant work experience are welcome to apply and will be considered on an individual basis.
For fees and funding options, please visit website to find out more
UCL offers a range of financial awards aimed at assisting both prospective and current students with their studies.
You will gain a solid foundation in understanding the interconnections between biotechnology, pharmaceuticals, and business. In particular, you will develop an entrepreneurial mindset, enabling you to identify opportunities for products, solutions, and innovations emerging from healthcare research. You will acquire practical skills related to various measures of biotechnology and pharmaceutical costs and outcomes, including a detailed understanding of pharmacoeconomic techniques such as Cost-Benefit Analysis, Cost-Effectiveness Analysis, Cost-Utility Analysis, Cost-Minimisation Analysis, and Cost-Consequence Analysis. This is supported by a critical understanding of the ethical, legal, and regulatory factors associated with biotech and pharma business development.
Paths to work after this programme:
Compulsory modules
Masters study opportunities at UCL Make your Master’s matter. For a real-world advantage, study at a world-class university and your Master’s will ta...
Wed 20 Nov 2024